RxDoctor Payments Data

Patrick Crandell, PA

Physician Assistant · Johnson City, NYNPI 1508298498

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.6% of the total across 421 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,944, 2.1 times the $913 reported in 2021. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,132in general payments, 2019–2025

Across 421 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$826
  • Novartis$653
  • E.r. Squibb & Sons, L.L.C.$472
  • Regeneron Healthcare Solutions, Inc.$465
  • Amgen$454
  • plus $3K from 17 others

What the payments were for

  • Food & beverage$6,81496%
  • Education$3174%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,132 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York →

Medicare billing

Part B allowed, 2024
$158,567
Medicare patients
734
Services billed
3,833

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa17$337,819
Taltz AutoinjectorIxekizumab30$256,698
Cosentyx Unoready PenSecukinumab23$225,121
Dupixent PenDupilumab26$112,028
Clobetasol Propionate161$6,873
Fluorouracil97$5,861
Ketoconazole161$2,667
Clindamycin Phosphate44$2,367
Tacrolimus14$1,957
Metronidazole38$1,647
Triamcinolone Acetonide151$1,468
Azelaic Acid16$1,423
Mometasone Furoate45$1,008
Ammonium Lactate38$833
Doxycycline Hyclate55$759

Paid to pharmacies, not to this prescriber.

Other physician assistant in Johnson City

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →